Cincinnati Insurance CO Gilead Sciences, Inc. Transaction History

Cincinnati Insurance CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 06, 2020	SELL	$72.34 - $84.0 $13.3 Million - $15.4 Million	-183,500 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $10 Million - $12.8 Million	-160,000 Reduced 46.58%	183,500 $13.7 Million
Q3 2018 Nov 06, 2018	BUY	$71.28 - $78.92 $19.1 Million - $21.1 Million	267,500 Added 351.97%	343,500 $26.5 Million
Q2 2017 Aug 08, 2017	BUY	N/A	76,000	76,000 $5.38 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Cincinnati Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Cincinnati Insurance CO with notifications on news.